Close
Close
Treatment Database
mRNA encoding human argininosuccinate lyase
Trade Name not avaiable
Orphan Indication Argininosuccinate lyase deficiency
USA Market Approval
USA Designation Date 18-09-2017
Sponsor PhaseRx, Inc.
410 West Harrison Street, Suite 300
Seattle, Washington, 98119
More about Argininosuccinic Aciduria
Free Newsletter
Videos